ICON vs Incyte
ICLR and INCY side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ICLR and INCY compare
Incyte grew revenue faster over the last twelve months (24.9% versus 1.7% for ICON).
Incyte keeps more of each dollar of sales as profit, with a net margin of 6.7% compared with 0.51% at ICON.
Incyte scores higher on the StockData Score (13 against 4 for ICON), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ICLR | INCY |
|---|---|---|
| Size and price | ||
| Market cap | – | $24.4B |
| Share price | $211.36 | $120.39 |
| Change, 1 year | 27.4% | 33.5% |
| Change, 5 years | −20.5% | 77.4% |
| Beta (5Y) | 1.24 | 0.45 |
| Employees | 40K | 2,844 |
| StockData Score | ||
| Total score | 4 | 13 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 64.0× |
| P/S | – | 4.1× |
| P/B | – | 4.3× |
| EV/EBITDA | – | 29.1× |
| PEG | – | 1.04 |
| Fair value | – | $66.29 |
| Margin of safety | – | −81.6% |
| Growth | ||
| Revenue growth (TTM) | 1.7% | 24.9% (better) |
| Revenue growth, 5Y average | 24.2% (better) | 14.0% |
| Net income growth (TTM) | −95.1% | −66.1% (better) |
| EPS growth (TTM) | −94.8% | −68.2% (better) |
| EPS growth, 5Y average | −14.0% | – |
| Profitability | ||
| Gross margin | 23.9% | 92.7% (better) |
| Operating margin | 3.6% | 10.4% (better) |
| Net margin | 0.51% | 6.7% (better) |
| FCF margin | 10.7% | – |
| Return on equity | 0.45% | 7.8% (better) |
| Return on invested capital | 2.0% | 13.9% (better) |
| Financial health | ||
| Debt / equity | 0.23 (better) | 0.00 |
| Net debt / EBITDA | 1.77 | – |
| Interest coverage | 1.5× | 268× (better) |
| Current ratio | 0.95 | 3.84 (better) |
| Altman Z-score | – | 10.75 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 105% | 100.0% |
| Held by insiders | 0.57% | 33.4% |
| Insider net buying, 12 months | −$4.0M (better) | −$58.0M |
| Superinvestors holding | 4 | – |
| Short interest, % of float | 3.7% | 7.4% |
Go deeper
- ICLR stock overview
- ICLR income statement
- ICLR valuation and score
- INCY stock overview
- INCY income statement
- INCY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.